Learn More
10603 Background: In Brazil, LABC remains a serious health problem, representing approx. 30% of all newly diagnosed breast cancers. Anthracycline-based neoadjuvant therapy is a standard treatment,(More)
602 Background: Thirty percent of newly diagnosed breast cancer patients (pts) at INCA are stage III. First-line anthracyclin-based NEO is an effective treatment, but about 30% of the pts will fail.(More)
  • 1